Faster Drug Discovery Design with WEKA on AWS

Clovertex Principal Architect Baris Guler and WEKA Director of Sales, Pruitt Chamness, co-presented at AWS re:Invent on their collaboration to enable cryo-EM data processing at scale. This solution allows scientists to access data quicker, drive results faster and focus on their research instead of infrastructure.

While traditional on-premises solutions struggle to handle different IO profiles, using WEKA on AWS provides scientists with the flexibility to expand capacity as needed and control the different IO profiles required for each stage of the drug discovery pipeline. With the ability to quickly analyze large amounts of data and speed up the drug discovery process, using WEKA with Clovertex services on AWS has the potential to accelerate time to market for new drugs and ultimately improve patient outcomes.

In this video, learn how Clovertex and WEKA are working towards changing the way scientists approach and manage their scientific workflows by understanding:

  • What is Cryo-EM and how does it fit into drug discovery
  • How workflows have traditionally been done in the cloud
  • What is WEKA and how it accelerates and simplifies workloads
  • How the WEKA data platform allows for testing of multiple users to replicate real-world scenarios
  • How using the WEKA data platform and Clovertex’s services on AWS accelerates the data pipeline and drug discovery process through improving end-to-end workflow efficiency
  • What this means for the future of drug discovery

For more information on how you can accelerate drug discovery using the WEKA platform and Clovertex’s services on AWS, contact us today.

Recent Posts

How Clovertex blends bespoke and off-the-rack cloud computing in Pharma

Cloud technology and High-Performance Computing (HPC) are swiftly emerging as essential tools for the pharmaceutical industry, finding relevance in both the research (discovery phase) and the development (clinical phase) processes. This shift towards more computational reliance in the cloud is not without reason.

Faster Drug Discovery Design with WEKA on AWS

Clovertex Principal Architect Baris Guler and WEKA Director of Sales, Pruitt Chamness, co-presented at AWS re:Invent on their collaboration to enable cryo-EM data processing at scale. This solution allows scientists to access data quicker, drive results faster and focus on their research instead of infrastructure.

Contact Us

Clovertex is hiring.
To apply, visit the Careers page.

Head Office (USA)

800 Boylston Street, Floor 16
Boston, MA 02199
[email protected]
+1 (508) 395-3423

Regional Office (India)

Workafella Cyber Crown, Hi-Tech City
Sec-II, Village, HUDA Techno Enclave
Suite #204, 2nd Floor Hyderabad
500081, Telangana India